Eisai, Biogen launch subcutaneous Leqembi autoinjector in the U.S.
Go back to Eisai, Biogen launch subcutaneous Leqembi autoinjector in the U.S.| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 216.01 -0.16 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.17 | 52 Week High | $333.65 | |||
| Open | $216.41 | 52 Week Low | $223.02 | |||
| Day High | $218.29 | P/E | 27.66 | |||
| Day Low | $214.81 | EPS | $7.81 | |||
| Volume | 606,494 | |||||

